BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8626516)

  • 1. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
    Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
    J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2.
    Loetscher P; Seitz M; Clark-Lewis I; Baggiolini M; Moser B
    FEBS Lett; 1994 Mar; 341(2-3):187-92. PubMed ID: 8137938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
    Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
    J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A.
    Schraufstätter IU; Ma M; Oades ZG; Barritt DS; Cochrane CG
    J Biol Chem; 1995 May; 270(18):10428-31. PubMed ID: 7737976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein.
    Sticht H; Auer M; Schmitt B; Besemer J; Horcher M; Kirsch T; Lindley IJ; Rösch P
    Eur J Biochem; 1996 Jan; 235(1-2):26-35. PubMed ID: 8631339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes.
    Geiser T; Dewald B; Ehrengruber MU; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1993 Jul; 268(21):15419-24. PubMed ID: 8340371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
    Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
    J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.
    Heinrich JN; O'Rourke EC; Chen L; Gray H; Dorfman KS; Bravo R
    Mol Cell Biol; 1994 May; 14(5):2849-61. PubMed ID: 8164648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF; Sullivan G; Lolis E
    Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orphan mouse receptor interleukin (IL)-8R beta binds N51. Structure-function analysis using N51/IL-8 chimeric molecules.
    Heinrich JN; Bravo R
    J Biol Chem; 1995 Mar; 270(10):4987-9. PubMed ID: 7890604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.
    Jones SA; Wolf M; Qin S; Mackay CR; Baggiolini M
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6682-6. PubMed ID: 8692878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N51 competes 125I-interleukin (IL)-8 binding to IL-8R beta but not IL-8R alpha. Structure-function analysis using N51/IL-8 chimeric molecules.
    Heinrich JN; Bravo R
    J Biol Chem; 1995 Nov; 270(47):28014-7. PubMed ID: 7499284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2. Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2).
    Jones SA; Moser B; Thelen M
    FEBS Lett; 1995 May; 364(2):211-4. PubMed ID: 7750573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of CINC/Gro investigated by heteronuclear NMR.
    Hanzawa H; Haruyama H; Konishi K; Watanabe K; Tsurufuji S
    J Biochem; 1998 Jan; 123(1):62-70. PubMed ID: 9504410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.
    Gayle RB; Sleath PR; Srinivason S; Birks CW; Weerawarna KS; Cerretti DP; Kozlosky CJ; Nelson N; Vanden Bos T; Beckmann MP
    J Biol Chem; 1993 Apr; 268(10):7283-9. PubMed ID: 8463264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors.
    Norgauer J; Metzner B; Czech W; Schraufstatter I
    Inflamm Res; 1996 Mar; 45(3):127-31. PubMed ID: 8689391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.